Vaccine-derived NSP2 segment in rotaviruses from vaccinated children with gastroenteritis in Nicaragua

Infection, Genetics and Evolution

Volumn 12, Issue 6, 2012, Pages 1282-1294

  Bucardo, Filemón ^a   Rippinger, Christine M ^b   Svensson, Lennart ^c   Patton, John T ^b  

^a UNIVERSITY OF LEÓN   (Spain)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Genomics; RotaTeq; Rotavirus; Vaccine

Indexed keywords

CAPSID PROTEIN; EPITOPE; PROTEIN VP4; PROTEIN VP7; ROTAVIRUS VACCINE;

ANTIGEN DETECTION; ANTIGENICITY; ARTICLE; CHILD; CHILD CARE; CONTROLLED STUDY; FEMALE; GENE SEQUENCE; GENETIC DRIFT; GENETIC IDENTIFICATION; GENETIC REASSORTMENT; GENOTYPE; HUMAN; HUMAN ROTAVIRUS; MAJOR CLINICAL STUDY; MALE; N2 NSP2 GENE; NICARAGUA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; PRIORITY JOURNAL; ROTAVIRUS INFECTION; SEQUENCE HOMOLOGY; VACCINATION; VACCINE FAILURE; VIRAL GASTROENTERITIS; VIRUS GENE; VIRUS GENOME; VIRUS STRAIN;

AMINO ACID SEQUENCE; ANTIGENS, VIRAL; CAPSID PROTEINS; CHILD, PRESCHOOL; DIARRHEA; FEMALE; GASTROENTERITIS; GENOTYPE; HUMANS; INFANT; MALE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NICARAGUA; PHYLOGENY; REASSORTANT VIRUSES; RNA-BINDING PROTEINS; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; SEQUENCE ALIGNMENT; VACCINES, ATTENUATED; VIRAL NONSTRUCTURAL PROTEINS;

BOVINAE; MIRIDAE; ROTAVIRUS;

EID: 84861928360     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2012.03.007     Document Type: Article

References (58)

1. Aoki S.T., Settembre E.C., Trask S.D., Greenberg H.B., Harrison S.C., Dormitzer P.R. Structure of rotavirus outer-layer protein VP7 bound with a neutralizing Fab. Science 2009, 324:1444-1447.
2. Bucardo F., Nordgren J., Carlsson B., Paniagua M., Lindgren P.E., Espinoza F., Svensson L. Pediatric norovirus diarrhea in Nicaragua. J. Clin. Microbiol. 2008, 46:2573-2580.
3. Carvalho-Costa F.A., Volotao Ede M., de Assis R.M., Fialho A.M., de Andrade Jda S., Rocha L.N., Tort L.F., da Silva M.F., Gomez M.M., de Souza P.M., Leite J.P. Laboratory-based rotavirus surveillance during the introduction of a vaccination program, Brazil, 2005-2009. Pediatr. Infect. Dis. J. 2011, 30:S35-S41.
4. Chan J., Nirwati H., Triasih R., Bogdanovic-Sakran N., Soenarto Y., Hakimi M., Duke T., Buttery J.P., Bines J.E., Bishop R.F., Kirkwood C.D., Danchin M.D. Maternal antibodies to rotavirus: could they interfere with live rotavirus vaccines in developing countries?. Vaccine 2011, 29:1242-1247.
5. Clark H.F., Offit P.A., Plotkin S.A., Heaton P.M. The new pentavalent rotavirus vaccine composed of bovine (strain WC3)-human rotavirus reassortants. Pediatr. Infect. Dis. J. 2006, 25:577-583.
6. Correia J.B., Patel M.M., Nakagomi O., Montenegro F.M., Germano E.M., Correia N.B., Cuevas L.E., Parashar U.D., Cunliffe N.A., Nakagomi T. Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serotypically unrelated G2P[4] strains in Brazil. J. Infect. Dis. 2010, 201:363-369.
7. Coulson B. VP4 and VP7 typing using monoclonal antibodies. Arch. Virol. Suppl. 1996, 12:113-118.
8. Coulson B.S., Kirkwood C. Relation of VP7 amino acid sequence to monoclonal antibody neutralization of rotavirus and rotavirus monotype. J. Virol. 1991, 65:5968-5974.
9. Donker N.C., Foley M., Tamvakis D.C., Bishop R., Kirkwood C.D. Identification of an antibody-binding epitope on the rotavirus A non-structural protein NSP2 using phage display analysis. J. Gen. Virol. 2011, 92:2374-2382.
10. Dormitzer P.R., Sun Z.Y., Wagner G., Harrison S.C. The rhesus rotavirus VP4 sialic acid binding domain has a galectin fold with a novel carbohydrate binding site. EMBO J. 2002, 21:885-897.
11. Dyall-Smith M.L., Lazdins I., Tregear G.W., Holmes I.H. Location of the major antigenic sites involved in rotavirus serotype-specific neutralization. Proc. Natl. Acad. Sci. USA 1986, 83:3465-3468.
12. Estes M.K., Kapikian A. Rotaviruses. Fields Virology 2007, 1917-1975. Kluwer Health/Lippincott, Williams and Wilkins, Philadelphia. D.M. Knipe, P.M. Howley, D.E. Griffin, R.A. Lamb, M. Martin, B. Roizman, S.E. Straus (Eds.).
13. Gentsch J.R., Glass R.I., Woods P., Gouvea V., Gorziglia M., Flores J., Das B.K., Bhan M.K. Identification of group A rotavirus gene 4 types by polymerase chain reaction. J. Clin. Microbiol. 1992, 30:1365-1373.
14. Gomara M.I., Cubitt D., Desselberger U., Gray J. Amino acid substitution within the VP7 protein of G2 rotavirus strains associated with failure to serotype. J. Clin. Microbiol. 2001, 39:3796-3798.
15. Gouvea V., Glass R.I., Woods P., Taniguchi K., Clark H.F., Forrester B., Fang Z.Y. Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J. Clin. Microbiol. 1990, 28:276-282.
16. Goveia M.G., DiNubile M.J., Dallas M.J., Heaton P.M., Kuter B.J. Efficacy of pentavalent human-bovine (WC3) reassortant rotavirus vaccine based on breastfeeding frequency. Pediatr. Infect. Dis. J. 2008, 27:656-658. REST Study Team.
17. Greig S.L., Berriman J.A., O'Brien J.A., Taylor J.A., Bellamy A.R., Yeager M.J., Mitra A.K. Structural determinants of rotavirus subgroup specificity mapped by cryo-electron microscopy. J. Mol. Biol. 2006, 356:209-221.
18. Guindon S., Gascuel O. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst. Biol. 2003, 52:696-704.
19. Gurgel R.Q., Cuevas L.E., Vieira S.C., Barros V.C., Fontes P.B., Salustino E.F., Nakagomi O., Nakagomi T., Dove W., Cunliffe N., Hart C.A. Predominance of rotavirus P[4]G2 in a vaccinated population, Brazil. Emerg. Infect. Dis. 2007, 13:1571-1573.
20. Heaton P.M., Ciarlet M. Vaccines: the pentavalent rotavirus vaccine: discovery to licensure and beyond. Clin. Infect. Dis. 2007, 45:1618-1624.
21. Heiman E.M., McDonald S.M., Barro M., Taraporewala Z.F., Bar-Magen T., Patton J.T. Group A human rotavirus genomics: evidence that gene constellations are influenced by viral protein interactions. J. Virol. 2008, 82:11106-11116.
22. Hoshino Y., Kapikian A.Z. Classification of rotavirus VP4 and VP7 serotypes. Arch. Virol. Suppl. 1996, 12:99-111.
23. Hoshino Y., Honma S., Jones R.W., Ross J., Santos N., Gentsch J.R., Kapikian A.Z., Hesse R.A. A porcine G9 rotavirus strain shares neutralization and VP7 phylogenetic sequence lineage 3 characteristics with contemporary human G9 rotavirus strains. Virology 2005, 332:177-188.
24. Iturriza-Gomara M., Kang G., Gray J. Rotavirus genotyping: keeping up with an evolving population of human rotaviruses. J. Clin. Virol. 2004, 31:259-265.
25. Iturriza-Gomara M., Dallman T., Banyai K., Bottiger B., Buesa J., Diedrich S., Fiore L., Johansen K., Koopmans M., Korsun N., Koukou D., Kroneman A., Laszlo B., Lappalainen M., Maunula L., Marques A.M., Matthijnssens J., Midgley S., Mladenova Z., Nawaz S., Poljsak-Prijatelj M., Pothier P., Ruggeri F.M., Sanchez-Fauquier A., Steyer A., Sidaraviciute-Ivaskeviciene I., Syriopoulou V., Tran A.N., Usonis V., M V.A.N.R., A D.E.R., Gray J. Rotavirus genotypes co-circulating in Europe between 2006 and 2009 as determined by EuroRotaNet, a pan-European collaborative strain surveillance network. Epidemiol. Infect. 2011, 139:895-909.
26. Jayaram H., Taraporewala Z., Patton J.T., Prasad B.V. Rotavirus protein involved in genome replication and packaging exhibits a HIT-like fold. Nature 2002, 417:311-315.
27. Jiang X., Jayaram H., Kumar M., Ludtke S.J., Estes M.K., Prasad B.V. Cryoelectron microscopy structures of rotavirus NSP2-NSP5 and NSP2-RNA complexes: implications for genome replication. J. Virol. 2006, 80:10829-10835.
28. Johansson E., Istrate C., Charpilienne A., Cohen J., Hinkula J., Poncet D., Svensson L., Johansen K. Amount of maternal rotavirus-specific antibodies influence the outcome of rotavirus vaccination of newborn mice with virus-like particles. Vaccine 2008, 26:778-785.
29. Kumar M., Jayaram H., Vasquez-Del Carpio R., Jiang X., Taraporewala Z.F., Jacobson R.H., Patton J.T., Prasad B.V. Crystallographic and biochemical analysis of rotavirus NSP2 with nucleotides reveals a nucleoside diphosphate kinase-like activity. J. Virol. 2007, 81:12272-12284.
30. López S., Espinosa R., Greenberg H.B., Arias C.F. Mapping the subgroup epitopes of rotavirus protein VP6. Virology 1994, 204:153-162.
31. Maan S., Maan N.S., van Rijn P.A., van Gennip R.G., Sanders A., Wright I.M., Batten C., Hoffmann B., Eschbaumer M., Oura C.A., Potgieter A.C., Nomikou K., Mertens P.P. Full genome characterisation of bluetongue virus serotype 6 from the Netherlands 2008 and comparison to other field and vaccine strains. PLoS One 2010, 5:e10323.
32. Madhi S.A., Cunliffe N.A., Steele D., Witte D., Kirsten M., Louw C., Ngwira B., Victor J.C., Gillard P.H., Cheuvart B.B., Han H.H., Neuzil K.M. Effect of human rotavirus vaccine on severe diarrhea in African infants. N. Engl. J. Med. 2010, 362:289-298.
33. Matthijnssens J., Ciarlet M., Heiman E., Arijs I., Delbeke T., McDonald S.M., Palombo E.A., Iturriza-Gomara M., Maes P., Patton J.T., Rahman M., Van Ranst M. Full genome-based classification of rotaviruses reveals a common origin between human Wa-Like and porcine rotavirus strains and human DS-1-like and bovine rotavirus strains. J. Virol. 2008, 82:3204-3219.
34. Matthijnssens J., Joelsson D.B., Warakomski D.J., Zhou T., Mathis P.K., van Maanen M.H., Ranheim T.S., Ciarlet M. Molecular and biological characterization of the 5 human-bovine rotavirus (WC3)-based reassortant strains of the pentavalent rotavirus vaccine, RotaTeq. Virology 2010, 403:111-127.
35. Matthijnssens J., Ciarlet M., McDonald S.M., Attoui H., Banyai K., Brister J.R., Buesa J., Esona M.D., Estes M.K., Gentsch J.R., Iturriza-Gomara M., Johne R., Kirkwood C.D., Martella V., Mertens P.P., Nakagomi O., Parreno V., Rahman M., Ruggeri F.M., Saif L.J., Santos N., Steyer A., Taniguchi K., Patton J.T., Desselberger U., Van Ranst M. Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG). Arch. Virol. 2011, 156:1397-1413.
36. McDonald S.M., Matthijnssens J., McAllen J.K., Hine E., Overton L., Wang S., Lemey P., Zeller M., Van Ranst M., Spiro D.J., Patton J.T. Evolutionary dynamics of human rotaviruses: balancing reassortment with preferred genome constellations. PLoS Pathog. 2009, 5:e1000634.
37. Moon S.S., Wang Y., Shane A.L., Nguyen T., Ray P., Dennehy P., Baek L.J., Parashar U., Glass R.I., Jiang B. Inhibitory effect of breast milk on infectivity of live oral rotavirus vaccines. Pediatr. Infect. Dis. J. 2010, 29:919-923.
38. Nakagomi T., Cuevas L.E., Gurgel R.G., Elrokhsi S.H., Belkhir Y.A., Abugalia M., Dove W., Montenegro F.M., Correia J.B., Nakagomi O., Cunliffe N.A., Hart C.A. Apparent extinction of non-G2 rotavirus strains from circulation in Recife, Brazil, after the introduction of rotavirus vaccine. Arch. Virol. 2008, 153:591-593.
39. Nordgren J., Bucardo F., Dienus O., Svensson L., Lindgren P.E. Novel light-upon-extension real-time PCR assays for detection and quantification of genogroup I and II noroviruses in clinical specimens. J. Clin. Microbiol. 2008, 46:164-170.
40. Parashar U.D., Hummelman E.G., Bresee J.S., Miller M.A., Glass R.I. Global illness and deaths caused by rotavirus disease in children. Emerg. Infect. Dis. 2003, 9:565-572.
41. Parashar U.D., Burton A., Lanata C., Boschi-Pinto C., Shibuya K., Steele D., Birmingham M., Glass R.I. Global mortality associated with rotavirus disease among children in 2004. J. Infect. Dis. 2009, 200(Suppl. 1):S9-S15.
42. Patel M., Pedreira C., De Oliveira L.H., Tate J., Orozco M., Mercado J., Gonzalez A., Malespin O., Amador J.J., Umana J., Balmaseda A., Perez M.C., Gentsch J., Kerin T., Hull J., Mijatovic S., Andrus J., Parashar U. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. JAMA 2009, 301:2243-2251.
43. Patel M., Shane A.L., Parashar U.D., Jiang B., Gentsch J.R., Glass R.I. Oral rotavirus vaccines: how well will they work where they are needed most?. J. Infect. Dis. 2009, 200(Suppl. 1):S39-48.
44. Samajdar S., Varghese V., Barman P., Ghosh S., Mitra U., Dutta P., Bhattacharya S.K., Narasimham M.V., Panda P., Krishnan T., Kobayashi N., Naik T.N. Changing pattern of human group A rotaviruses: emergence of G12 as an important pathogen among children in eastern India. J. Clin. Virol. 2006, 36:183-188.
45. Santos N., Hoshino Y. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev. Med. Virol. 2005, 15:29-56.
46. Taraporewala Z.F., Jiang X., Vasquez-Del Carpio R., Jayaram H., Prasad B.V., Patton J.T. Structure-function analysis of rotavirus NSP2 octamer by using a novel complementation system. J. Virol. 2006, 80:7984-7994.
47. Tate J.E., Burton A.H., Boschi-Pinto C., Steele A.D., Duque J., Parashar U.D. 2008 Estimate of worldwide rotavirus-associated mortality in children younger than 5years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect. Dis. 2012, 12:136-141.
48. Vasquez-Del Carpio R., Gonzalez-Nilo F.D., Riadi G., Taraporewala Z.F., Patton J.T. Histidine triad-like motif of the rotavirus NSP2 octamer mediates both RTPase and NTPase activities. J. Mol. Biol. 2006, 362:539-554.
49. Vesikari T., Matson D.O., Dennehy P., Van Damme P., Santosham M., Rodriguez Z., Dallas M.J., Heyse J.F., Goveia M.G., Black S.B., Shinefield H.R., Christie C.D., Ylitalo S., Itzler R.F., Coia M.L., Onorato M.T., Adeyi B.A., Marshall G.S., Gothefors L., Campens D., Karvonen A., Watt J.P., O'Brien K.L., DiNubile M.J., Clark H.F., Boslego J.W., Offit P.A., Heaton P.M. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N. Engl. J. Med. 2006, 354:23-33.
50. Vesikari T., Karvonen A., Prymula R., Schuster V., Tejedor J.C., Cohen R., Meurice F., Han H.H., Damaso S., Bouckenooghe A. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2years of life in European infants: randomised, double-blind controlled study. Lancet 2007, 370:1757-1763.
51. Vesikari, T., Prymula, R., Schuster, V., Tejedor, J.C., Cohen, R., Bouckenooghe, A., Damaso, S., Han, H.H., 2012. Efficacy and immunogenicity of live-attenuated human rotavirus vaccine in breast-fed and formula-fed European infants. Pediatr. Infect. Dis. J., January 5 [Epub ahead of print].
52. WHO, 2009. Rotavirus vaccines: an update. WHO, Weekly Epidemiol. Rec. 84, 533-540.
53. WHO, 2011. Global rotavirus information and surveillance bulletin. Reporting Period: January through December 2010. World Health Organization, vol. 4.
54. Wobudeya E., Bachou H., Karamagi C.K., Kalyango J.N., Mutebi E., Wamani H. Breastfeeding and the risk of rotavirus diarrhea in hospitalized infants in Uganda: a matched case control study. BMC Pediatr. 2011, 11:17.
55. Yen C., Jakob K., Esona M.D., Peckham X., Rausch J., Hull J.J., Whittier S., Gentsch J.R., LaRussa P. Detection of fecal shedding of rotavirus vaccine in infants following their first dose of pentavalent rotavirus vaccine. Vaccine 2011, 29:4151-4155.
56. Yen C., Tate J.E., Patel M.M., Cortese M.M., Lopman B., Fleming J., Lewis K., Jiang B., Gentsch J., Steele D., Parashar U.D. Rotavirus vaccines: update on global impact and future priorities. Hum. Vaccine 2011, 7:1282-1290.
57. Zaman K., Dang D.A., Victor J.C., Shin S., Yunus M., Dallas M.J., Podder G., Vu D.T., Le T.P., Luby S.P., Le H.T., Coia M.L., Lewis K., Rivers S.B., Sack D.A., Schodel F., Steele A.D., Neuzil K.M., Ciarlet M. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet 2010, 376:615-623.
58. Zeller M., Patton J.T., Heylen E., DeCoster S., Ciarlet M., Van Ranst M., Matthijnssens J. Genetic analyses reveal differences in the VP7 and VP4 antigenic epitopes between human rotaviruses circulating in Belgium and rotaviruses in Rotarix and RotaTeq. J. Clin. Microbiol. 2012, 50:966-976.